NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

WGRX

Wellgistics Health Inc

Apr 23 • 02:51PM ET

3.95

Dollar change +0.45
Percentage change 13.00	%

Healthcare • Pharmaceutical Retailers • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.13	Insider Own	85.20%	Shs Outstand	51.94M	Perf Week	0.24%
Market Cap	205.13M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.69M	Perf Month	-0.02%
Income	-6.86M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	0.75%	Perf Quarter	-
Sales	18.13M	P/S	11.31	EPS this Y	-	Inst Trans	0.20%	Short Ratio	0.33	Perf Half Y	-
Book/sh	0.13	P/B	30.46	EPS next Y	-	ROA	-23.78%	Short Interest	0.06M	Perf Year	-
Cash/sh	0.02	P/C	199.16	EPS next 5Y	-	ROE	-357.65%	52W Range	2.32 - 5.69	Perf YTD	3.66%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-35.55%	52W High	-30.59%	Beta	-
Dividend TTM	-	Quick Ratio	0.13	Sales past 5Y	0.00%	Gross Margin	3.60%	52W Low	70.23%	ATR (14)	0.70
Dividend Ex-Date	-	Current Ratio	0.38	EPS Y/Y TTM	-136.98%	Oper. Margin	-33.90%	RSI (14)	51.53	Volatility	15.96% 20.26%
Employees	-	Debt/Eq	3.73	Sales Y/Y TTM	-	Profit Margin	-37.82%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	1.86	EPS Q/Q	-302.90%	Payout	-	Rel Volume	0.74	Prev Close	3.49
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	174.53K	Price	3.95
SMA20	1.47%	SMA50	11.03%	SMA200	11.03%	Trades		Volume	107,794	Change	13.00%

Apr-15-25 07:40AM	CEO of Wellgistics Health Converts $1.5 Million of Debt to Equity at IPO Price (ACCESSWIRE)
Apr-10-25 07:40AM	Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue (ACCESSWIRE) -9.07%
Mar-27-25 08:05AM	Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025 (GlobeNewswire)
Mar-18-25 07:40AM	Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models (GlobeNewswire) +14.61%
Mar-04-25 05:18PM	Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure (GlobeNewswire)
07:40AM	Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.Finviz Elite
07:40AM	Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND (GlobeNewswire)
Feb-26-25 07:40AM	Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market (GlobeNewswire)
Feb-25-25 01:15PM	D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering (ACCESS Newswire) -9.90%
Feb-24-25 04:05PM	Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering (GlobeNewswire) -20.47%
Feb-21-25 08:05AM	Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering (GlobeNewswire)

Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

WGRX

Wellgistics Health Inc

Upgrade your FINVIZ experience